iPredict Eye Screening vs KardiaPro
AI Verdict
Choose iPredict Eye Screening if…
Choose iPredict Eye Screening if your primary need is efficient, AI-powered screening for multiple retinal diseases like AMD, Diabetic Retinopathy, and Glaucoma, particularly in a primary care setting. This tool is ideal for rapidly screening a large patient population (e.g., diabetic patients for DR, individuals over 50 for AMD) and receiving quick, automated reports to identify those who need referral to an ophthalmologist.
View iPredict Eye Screening →Choose KardiaPro if…
Choose KardiaPro if your focus is on comprehensive remote patient monitoring for cardiovascular conditions, including ECG, blood pressure, and weight data. This platform is best suited for healthcare professionals managing patients with known or suspected arrhythmias, allowing for continuous data review, trend analysis, and informed clinical decision-making between appointments.
View KardiaPro →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | iPredict Eye Screening | KardiaPro |
|---|---|---|
| Pricing | Contact for pricing | Contact for pricing |
| Deployment | Cloud-based (Software as a Medical Device), accessible in primary care settings, clinics, hospitals, and online for telemedicine and prediction apps. | Cloud-hosted, Web-based |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
iPredict Eye ScreeningiPredict Eye Screening emphasizes ease of operation with a non-invasive, advanced touchscreen interface and fast results (test in <5 minutes, report in <60 seconds). KardiaPro, while web-based and designed for efficient data review, relies on external devices (KardiaMobile) for data capture, potentially adding a step to the user workflow for patients.
Clinical Value
iPredict Eye ScreeningiPredict Eye Screening offers AI-powered screening for multiple conditions (AMD, DR, Glaucoma) and risk prediction for systemic diseases like stroke and heart attack, with high reported accuracy (approx. 95% on average). KardiaPro focuses on remote monitoring of ECG, blood pressure, and weight data with FDA-cleared AI for arrhythmia detection, which is valuable but covers a narrower scope of conditions.
Pricing & Value
iPredict Eye ScreeningiPredict Eye Screening provides an estimated per-patient screening cost of $10-$20, which is transparent and a percentage of Medicare/commercial payor reimbursement. KardiaPro states it is reimbursable using existing CPT codes but requires contacting them for specific pricing, making its value proposition less immediately clear.
Enterprise Readiness
KardiaProKardiaPro explicitly states HIPAA compliance and SOC-2 certification, and offers seamless integration with KardiaMobile devices and KardiaStation for point-of-care solutions, along with EHR integration capabilities. iPredict Eye Screening mentions HIPAA compliance and EHR integration, but lacks the explicit SOC-2 certification and detailed integration ecosystem described by KardiaPro.
Innovation
iPredict Eye ScreeningiPredict Eye Screening stands out with its multi-disease screening capabilities from a single retinal image, including risk prediction for systemic diseases like stroke and heart attack, which is a novel approach in the field. While KardiaPro's remote monitoring and AI for arrhythmia detection are innovative, the concept of using retinal imaging for broader systemic health risk prediction offers a more expansive innovative scope.
Support & Docs
TieNeither tool provides explicit details about their support services or documentation within the given information. Both would require direct inquiry to assess the quality and availability of these resources.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | iPredict Eye Screening | KardiaPro |
|---|---|---|
| Tool Name | iPredict Eye Screening | KardiaPro |
| Company | iHealthScreen | AliveCor |
| Description | AI-powered screening tool for age-related macular degeneration (AMD) in patients aged 50 years and older, alongside screening for Diabetic Retinopathy (DR) and Glaucoma. The platform also provides risk prediction for systemic diseases like stroke and heart attack, integrating with EHR and telemedicine services. | Comprehensive web-based portal for remote monitoring of patient ECG, blood pressure, and weight data, with FDA-cleared AI for arrhythmia detection and other cardiac determinations. |
| Primary Categories | Cardiology AI, Neurology AI, Ophthalmology AI | Cardiology AI, Clinical Decision Support & Reference, Wearables & Remote Monitoring (RPM) |
| Key Features | AI-Based Screening for Diabetic Retinopathy (DR), Age-related Macular Degeneration (AMD), and Glaucoma; Electronic Health Record (EHR) Solutions; AI-Based Telemedicine Service; Image Analyzer for Retinal Vessel, Retinal Pathology, and OCT Inspector; Online Health Risk Prediction System for Diabetic, Stroke, and Heart Attack patients; Fast results: test completed in less than 5 minutes, report in under 60 seconds; High accuracy: approximately 95% on average (AMD sensitivity 86.86%, specificity 94.13%); Easy to operate, non-invasive, with an advanced touchscreen interface | Comprehensive web-based portal for remote monitoring; ECG, blood pressure, and weight data management; FDA-cleared AI for arrhythmia detection; Customizable ECG inbox for efficient data review; Automated summary reports and trend visualization; Seamless integration with KardiaMobile and KardiaMobile 6L devices; Integration with KardiaStation for point-of-care solutions; HIPAA-compliant and SOC-2 certified data handling |
Videos
Demos, reviews, and walkthroughs featuring iPredict Eye Screening and KardiaPro.
Frequently Asked Questions
More Comparisons
More matchups featuring iPredict Eye Screening or KardiaPro
Backers
Who funded each tool's parent company.